ARTICLE | Company News
Exelixis Pharmaceuticals Inc., Pharmacia & Upjohn deal
November 8, 1999 8:00 AM UTC
The companies expanded their collaboration focused on the identification of novel targets in Alzheimer's disease and metabolic syndromes to include the use of Exelixis' Mechanism of Action technology ...